The antinociceptive effect of reversible monoamine oxidase-A inhibitors in a mouse neuropathic pain model

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 44, Issue , 2013, Pages 136-142

  Villarinho, Jardel Gomes ^a   Pinheiro, Kelly de Vargas ^a   Pinheiro, Francielle de Vargas ^a   Oliveira, Sara Marchesan ^a   Machado, Pablo ^a   Martins, Marcos Antônio Pinto ^a   Bonacorso, Helio Gauze ^a   Zanatta, Nilo ^a   Fachinetto, Roselei ^a   Ferreira, Juliano ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

2 DMPI; Moclobemide; Neuropathy; Nociception; Pregabalin

Indexed keywords

2 (3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H IMIDAZOLE; AMINE OXIDASE (FLAVIN CONTAINING); MOCLOBEMIDE; MONOAMINE OXIDASE A INHIBITOR; NAUSEDRON; ONDANSETRON; PREGABALIN; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVITY; HYPERALGESIA; IC 50; LUMBAR SPINAL CORD; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PAIN PARAMETERS; PAW WITHDRAWAL THRESHOLD; SCIATIC NERVE INJURY;

ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; ANISOLES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; HYPERALGESIA; IMIDAZOLINES; MALE; MICE; MOCLOBEMIDE; MONOAMINE OXIDASE; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; ROTAROD PERFORMANCE TEST; TIME FACTORS;

EID: 84875255823     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.02.005     Document Type: Article

References (55)

1. 3 receptor-mediated antinociception: possible release of GABA. J Neurosci 1991, 11:1881-1888.
2. Alloui A., Chassaing C., Schmidt J., Ardid D., Dubray C., Cloarec A., et al. Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats. Eur J Pharmacol 2002, 443:71-77.
3. Apaydin S., Goldeli E., Uyar M., Erhan E., Yegul I., Tuglular I. The antinociceptive effect of moclobemide on the vocalization threshold to paw pressure in a rat model of unilateral mononeuropathy. Pharmacol Res 2001, 44:503-507.
4. 3 spinal receptor involvement in acute pain in humans. Anesth Analg 2002, 94:1553-1557.
5. Ardid D., Jourdan D., Mestre C., Villanueva L., Le Bars D., Eschalier A. Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat. Brain Res 1995, 695:253-256.
6. Bardin L., Lavarenne J., Eschalier A. Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain 2000, 86:11-18.
7. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
8. Berrocoso E., Benito M.D., Micó J.A. Role of serotonin 5-HT1A and opioid receptors in the antiallodynic effect of tramadol in the chronic constriction injury model of neuropathic pain in rats. Psychopharmacology (Berl) 2007, 193:97-105.
9. Bianchi M., Mantegazza P., Panerai A.E. Effects of two different reversible monoamine oxidase-A inhibitors on nociceptive thresholds in the rat. Eur J Pharmacol 1992, 219:113-116.
10. 3 receptors. Eur J Pharmacol 2012, 681:44-49.
11. Brenchat A., Zamanillo D., Hamon M., Romero L., Vela J.M. Role of peripheral versus spinal 5-HT(7) receptors in the modulation of pain undersensitizing conditions. Eur J Pain 2012, 16:72-81.
12. Bridges D., Thompson S.W., Rice A.S. Mechanisms of neuropathic pain. Br J Anaesth 2001, 87:12-26.
13. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63.
14. Coquoz D., Porchet H.C., Dayer P. Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers. Clin Pharmacol Ther 1993, 54:339-344.
15. Costigan M., Scholz J., Woolf C.J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009, 32:1-32.
16. Da Prada M., Kettler R., Keller H.H., Burkard W.P., Muggli-Maniglio D., Haefely W.E. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther 1989, 248:400-414.
17. Dina O.A., Khasar S.G., Alessandri-Haber N., Bogen O., Chen X., Green P.G., et al. Neurotoxic catecholamine metabolite in nociceptors contributes to painful peripheral neuropathy. Eur J Neurosci 2008, 28:1180-1190.
18. Dixon W.J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20:441-462.
19. 7 receptors. Eur J Pharmacol 2012, 677:93-101.
20. Dworkin R.H., O'Connor A.B., Backonja M., Farrar J.T., Finnerup N.B., Jensen T.S., et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007, 132:237-251.
21. Gajraj N.M. Pregabalin: its pharmacology and use in pain management. Anesth Analg 2007, 105:1805-1815.
22. Giordano J. Analgesic profile of centrally administered 2-methylserotonin against acute pain in rats. Eur J Pharmacol 1991, 199:233-236.
23. Godoy M.C., Fighera M.R., Souza F.R., Flores A.E., Rubin M.A., Oliveira M.R., et al. Alpha 2-adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolines, but not of dipyrone. Eur J Pharmacol 2004, 496:93-97.
24. Goettl V.M., Huang Y., Hackshaw K.V., Stephens R.L. Reduced basal release of serotonin from the ventrobasal thalamus of the rat in a model of neuropathic pain. Pain 2002, 99:359-366.
25. Hains B.C., Everhart A.W., Fullwood S.D., Hulsebosch C.E. Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat. Exp Neurol 2002, 175:347-362.
26. 3 serotonin receptor analgesia. Anesthesiology 2012, 117:389-398.
27. 3A receptor subunit is expressed in a subpopulation of GABAergic and enkephalinergic neurons in the mouse dorsal spinal cord. Neurosci Lett 2008, 441:1-6.
28. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980, 67:313-316.
29. Jeong C.Y., Choi J.I., Yoon M.H. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol 2004, 502:205-211.
30. Kawamata T., Omote K., Toriyabe M., Kawamata M., Namiki A. Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord. Anesthesiology 2002, 96:1175-1182.
31. 3 receptors evokes GABA release in the spinal cord. Brain Res 2003, 978:250-255.
32. Kawamura M., Ohara H., Go K., Koga Y., Ienaga K. Neurotropin induces antinociceptive effect by enhancing descending pain inhibitory systems involving 5-HT3 and noradrenergic alpha2 receptors in spinal dorsal horn. Life Sci 1998, 62:2181-2190.
33. Liu F.Y., Qu X.X., Ding X., Cai J., Jiang H., Wan Y., et al. Decrease in the descending inhibitory 5-HT system in rats with spinal nerve ligation. Brain Res 2010, 1330:45-60.
34. Matsumoto T., Suzuki O., Furuta T., Asai M., Kurokawa Y., Rimura Y., et al. A sensitive fluorometric assay for serum monoamine oxidase with kynuramine as substrate. Clin Biochem 1985, 18:126-129.
35. Menkes D.B., Fawcett J.P., Busch A.F., Jones D. Moclobemide in chronic neuropathic pain: preliminary case reports. Clin J Pain 1995, 11:134-138.
36. Micó J.A., Ardid D., Berrocoso E., Eschalier A. Antidepressants and pain. Trends Pharmacol Sci 2006, 27:348-354.
37. Millan M.J. Descending control of pain. Prog Neurobiol 2002, 66:355-474.
38. Miura H., Naoi M., Nakahara D., Ohta T., Nagatsu T. Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice. Pharmacol Biochem Behav 1996, 53:469-475.
39. Nakajima K., Obata H., Iriuchijima N., Saito S. An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat. Pain 2012, 153:990-997.
40. Okazaki R., Namba H., Yoshida H., Okai H., Miura T., Kawamura M. The antiallodynic effect of neurotropin is mediated via activation of descending pain inhibitory systems in rats with spinal nerve ligation. Anesth Analg 2008, 107:1064-1069.
41. 3 receptors: in vivo and in vitro evidence. J Pharmacol Exp Ther 1996, 278:8-14.
42. Pirildar S., Sezgin U., Elbi H., Uyar M., Zileli B. A preliminary open-label study of moclobemide treatment of pain disorder. Psychopharmacol Bull 2003, 37:127-134.
43. 2 receptors in the rat brain. Life Sci 1997, 60:1393-1397.
44. Sant'Anna G.S., Machado P., Sauzem P.D., Rosa F.A., Rubin M.A., Ferreira J., et al. Ultrasound promoted synthesis of 2-imidazolines in water: a greener approach toward monoamine oxidase inhibitors. Bioorg Med Chem Lett 2009, 19:546-549.
45. Schreiber S., Getslev V., Weizman A., Pick C.G. The antinociceptive effect of moclobemide in mice is mediated by noradrenergic pathways. Neurosci Lett 1998, 253:183-186.
46. Sindrup S.H., Otto M., Finnerup N.B., Jensen T.S. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 2005, 96:399-409.
47. Sommer C., Schmidt C., George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 1998, 151:138-142.
48. Sounvoravong S., Nakashima M.N., Wada M., Nakashima K. Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice models of neuropathic pain. Eur J Pharmacol 2004, 484:217-223.
49. Stacey B.R. Management of peripheral neuropathic pain. Am J Phys Med Rehabil 2005, 84:S4-S16.
50. Treede R.D., Jensen T.S., Campbell J.N., Cruccu G., Dostrovsky J.O., Griffin J.W., et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70:1630-1635.
51. Villarinho J.G., Fachinetto R., Pinheiro F.D., Sant'Anna G.D., Machado P., Dombrowski P.A., et al. Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice. Prog Neuropsychopharmacol Biol Psychiatry 2012, 39:31-39.
52. Villarinho J.G., Oliveira S.M., Silva C.R., Cabreira T.N., Ferreira J. Involvement of monoamine oxidase B on models of postoperative and neuropathic pain in mice. Eur J Pharmacol 2012, 690:107-114.
53. Vogel C., Mössner R., Gerlach M., Heinemann T., Murphy D.L., Riederer P., et al. Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci 2003, 23:708-715.
54. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
55. Youdim M.B.H., Edmondson D., Tripton K.F. The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 2006, 7:295-309.